Insider Transactions in Q2 2025 at Dyne Therapeutics, Inc. (DYN)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 05
2025
|
Douglas Kerr Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,342
-1.43%
|
$17,446
$13.35 P/Share
|
|
Jun 05
2025
|
John Cox CEO & President |
SELL
Open market or private sale
|
Direct |
4,060
-2.78%
|
$52,780
$13.35 P/Share
|
|
Jun 05
2025
|
Johanna Friedl Naderer Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
146
-0.15%
|
$1,898
$13.35 P/Share
|